Cystoscopy and Ureteroscopy Market Growth Analysis & Trends 2025-2031

The Cystoscopy and Ureteroscopy Market size is projected to reach US$ 729.30 million by 2031 from US$ 459.11 million in 2024. The market is expected to register a CAGR of 6.9% from 2025 to 2031. 

Cystoscopy and Ureteroscopy Market Analysis

The increasing prevalence of urological diseases and development of technologically advanced and minimally invasive products are driving the cystoscopy and ureteroscopy market growth. Additionally, increasing awareness about urological problems and increasing awareness among the large population about urological disorders contribute to market growth. Expansion in emerging markets is expected to create ample opportunities for cystoscopy and ureteroscopy market in the coming years.

Cystoscopy and Ureteroscopy Market Overview

North America is projected to dominate the cystoscopy and ureteroscopy market, accounting for the largest share during the forecast period. Moreover, Asia Pacific is expected to register a significant CAGR during the forecast period owing to the aging population and an increase in urological disorders such as urinary tract infections and bladder cancer. Enhanced healthcare infrastructure, more hospitals, and a rise in ambulatory surgical centers in China, India, Japan, and South Korea have led to greater procedural volumes and the adoption of minimally invasive techniques. Technological advancements, such as flexible and digital video cystoscopes and ureteroscopes, offer improved patient comfort and high-definition imaging while reducing infection risks through disposable designs.

The entry of global leaders like Olympus and Stryker has fostered competition and accelerated innovation. Medical tourism in Singapore and Thailand further fuels demand for specialized urological treatments. Additionally, increased healthcare awareness and urbanization contribute to the rising incidence of urological conditions, creating a growing preference for outpatient procedures that require efficient and user-friendly cystoscopes and ureteroscopes.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Cystoscopy and Ureteroscopy Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Cystoscopy and Ureteroscopy Market Drivers and Opportunities

Market Drivers:

• Increasing Prevelance of Urological Diseases:

  The increasing prevalence of kidney stones, bladder cancer, prostate enlargement, urinary tract infections (UTIs), and other medical conditions related to the bladder and kidneys propels the demand for cystoscopy and ureteroscopy procedures for early diagnosis and treatment.

• Development of Technologically Advanced and Minimally Invasive Products:

  Technological developments in cystoscopy and ureteroscopy techniques have paved the way for the development of highly efficient and effective, and less invasive diagnostic and therapeutic options for urological diseases.

• Rising Awareness of Screening Program:

  National and regional screening initiatives for bladder and kidney health promote early detection and enhanced awareness leads to increased procedural volume for both diagnostic and therapeutic purposes.

Market Opportunities:

• Expansion in Emerging Economies:

  Rapid economic growth drives investments in healthcare infrastructure and new medical technologies in countries such as China, India, and South Africa. Initiatives taken toward the reinforcement of healthcare sectors include efforts to modernize urological care, raise awareness about early diagnosis, and expand health insurance coverage.

• Adoption of Single-use Cystoscopes and Ureteroscopes:

  Increasing demand for infection control, cost-effectiveness, and regulatory pressure on reprocessing reusable scopes are creating a surge in single-use endoscope adoption. This trend opens up opportunities for manufacturers to offer cost-competitive, high-performance disposable cystoscopes and ureteroscopes.

• Public-Private Partnerships and Government Funding:

  Governments are increasingly supporting early cancer detection programs, kidney health initiatives, and digital health infrastructure. This opens doors for public procurement contracts and strategic partnerships.

Cystoscopy and Ureteroscopy Market Report Segmentation Analysis

The cystoscopy and ureteroscopy market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:

By Product Type:

• Cystoscope:

  Cystoscopes feature high-definition imaging, 3D visualization, and fluorescence technologies, which enhance their diagnostic precision. Moreover, innovations such as flexible, miniaturized designs and improved light sources contribute to better access to hard-to-reach areas along with greater patient comfort. Additionally, the integration of artificial intelligence aids in the early detection of abnormalities, further improving diagnostic accuracy.

• Ureteroscope:

  Ureteroscopes features high-definition imaging, enhanced flexibility, and improved light sources, which enable more precise diagnostics and minimally invasive functionality. Innovations such as digital imaging and laser technology have revolutionized processes such as stone removal and tissue biopsies. Additionally, newer models are designed to be more compact and easier to operate, which improves patient comfort and surgical outcomes.

By Procedure:

• Stone Management:

  Cystoscopy and ureyeroscopy ureteroscopy aids in stone management by allowing direct visualization and removal of stones from the urinary tract using minimally invasive techniques. It reduces recovery time, minimizes complications, and provides effective treatment options, such as laser lithotripsy for stone fragmentation and extraction.

• Bladder Cancer:

  This procedure allows for the identification of tumors, abnormal growths, or lesions and facilitates biopsy or resection of any suspicious tissue.

• Benign prostatic hyperplasia: 

  Technological innovations have led to significant advancements in the diagnosis and treatment of BPH in recent years. New therapy regimens now prioritize minimally invasive procedures, which help reduce recovery time and improve patient outcomes.

• Others: 

  Cystoscopes and ureteroscopes are required in procedures such as the treatment of ureteral obstruction, tumor removal from the ureter or renal pelvis, and the placement of ureteral stents

By Technology:

• Fiber optic:

  Fiber optic technology plays a crucial role in cystoscopy and ureteroscopy, enabling healthcare providers to visualize the bladder and urinary tract with exceptional clarity.

• Video:

  Video technology in cystoscopy and ureteroscopy has transformed the examination of the bladder and urinary tract by providing high-quality, real-time digital imaging.

By Usage Type:

• Reusable:

  Reusable cystoscopy and ureteroscopy instruments are crucial for examining the bladder and urinary tract, providing a cost-effective and sustainable alternative to disposable devices.

• Single Use:

  Single-use cystoscopes and ureteroscopes have become popular due to their convenience and enhanced safety, partly owing to the reduced risk of infection.

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Geography:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The cystoscopy and ureteroscopy market in North America is expected to hold a significant share of the market. Increasing incidence of kidney stones (urolithiasis), bladder cancer, and urinary tract infections by the market players are factors likely to drive the market.

Cystoscopy and Ureteroscopy Market Regional Insights

The regional trends and factors influencing the Cystoscopy and Ureteroscopy Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Cystoscopy and Ureteroscopy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Cystoscopy and Ureteroscopy Market Report Scope

Cystoscopy and Ureteroscopy Market Players Density: Understanding Its Impact on Business Dynamics

The Cystoscopy and Ureteroscopy Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in Latin America, the Middle East, and Africa also have many untapped opportunities for cystoscopy and ureteroscopy providers to expand.

The cystoscopy and ureteroscopy market grows differently in each region. This is because of factors like increasing prevalence of increasing incidence of kidney stones (urolithiasis), bladder cancer, BPH and urinary tract infections along with new product launches and innovation. Below is a summary of market share and trends by region:

1. North America

• Market Share:

  Holds a significant portion of the global market

• Key Drivers:

  • Increasing incidence of kidney stones (urolithiasis), bladder cancer, and urinary tract infections
  • Technological Advancement
  • Robotics and wireless connectivity

• Trends:

  R&D and strategic collaborations to accelerate product launches and market penetration.

2. Europe

• Market Share:

  Substantial share due to Increasing prevalence of urological disorders

• Key Drivers:

• Increasing prevalence of urological conditions
• Intensified research and development activities
• The launch of advanced technologies across Europe

• Trends:

  Strategic involvement of leading medical technology firms

3. Asia Pacific

• Market Share:

  Fastest-growing region with rising market share every year

• Key Drivers:

  • Increasing incidence of bladder cancer, kidney stones, UTIs, and prostate-related disorders in countries
  • Rapid improvements in healthcare infrastructure, supported by increasing government investments in public health.

• Trends:

  Gradual adoption of digital imaging systems, HD cystoscopes, and AI-assisted diagnostics especially in advanced hospitals

4. South and Central America

• Market Share:

  Growing market with steady progress

• Key Drivers:

  • Rising rates of kidney stones, bladder cancer, prostate issues, and urinary tract infections
  • Growing Healthcare Investments and Infrastructure Development

• Trends:

  Rising Interest in AI and Digital Health

5. Middle East and Africa

• Market Share:

  Although small, but growing quickly

• Key Drivers:

• Expanding Healthcare infrastructure
• Medical Tourism and International Patient Flow

• Trends:

  Public Health Focus on Early Diagnosis and Cancer Care.

Cystoscopy and Ureteroscopy Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as Olympus Corp, Karl Storz SE & Co KG, Richard Wolf GmbH, Ambu A/S,. Regional and niche providers like Rudra Surgicals Advin Healthcare Pvt Lts are also adding to the competitive landscape across different regions.

This high level of competition urges companies to stand out by offering:

• Advanced Products
• Competitive pricing models
• Complaince with regulatory guidelines

Opportunities and Strategic Moves

• Increasing use of single-use cystoscope and ureteroscope is expected to prevent cross contamination also avoid reprocessing which is time consuming process which inturn reduces the cost of maintenance
• Companies are emphasizing clinical studies and regulatory approvals (including FDA clearances for new product categories), building strong clinical evidence to support adoption in hospitals and outpatient settings.
• Companies are targeting high-growth, under-penetrated markets in Asia-Pacific and Latin America for expansion, building local partnerships and increasing training initiatives. Manufacturers from Asia Pacific region are launching hybrid and price-competitive solutions for emerging markets, while Western start-ups innovate with AI software overlays that can bolt onto existing video stacks.

Major Companies operating in the Cystoscopy and Ureteroscopy Market are:

1. Olympus Corp
2. Karl Storz SE & Co KG
3. Richard Wolf GmbH
4. Ambu A/S
5. PENTAX Medical
6. Advin Health Care Pvt Ltd
7. Coloplast Corp
8. Cook Medical Holdings LLC
9. Electronics Services Centre (ESC Medicams)
10. Stryker Corp
11. Rudra Surgicals
12. Laborie
13. Teleflex Inc
14. NIDHI MEDITECH SYSTEMS
15. Pioneer Healthcare Technologies
16. Boston Scientific Corp
17. Ottomed Endoscopy
18. Becton Dickinson and Co
19. SCHÖLLY FIBEROPTIC GMBH
20. MicroPort Scientific Corp

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analysed during the course of research:

1. EMS Electro Medical Systems S.A.
2. Lumenis Ltd.
3. Polydiagnost GmbH
4. ProSurg Inc.
5. SIMEON Medical GmbH & Co. KG
6. OTU Medical Inc.
7. NeoScope Inc.
8. Elmed Medical Systems
9. Maxer Endoscopy GmbH (Erbe Vision)
10. ROCAMED
11. Zhuhai PUSEN Medical Technology Co., Ltd.
12. InnoMedicus
13. Dornier MedTech GmbH
14. Vimex Endoscopy
15. LocaMed Limited
16. Cantel Medical Corporation

Cystoscopy and Ureteroscopy Market News and Recent Developments

• Olympus Announces FDA Clearance of RenaFlex, Its First Single-use Flexible Ureteroscope

  Olympus, a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, announced the U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex, with full market availability. The RenaFlex single-use flexible ureteroscope system is used to access and visualize the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.

• Boston Scientific Receives FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System

  Boston Scientific Corporation announced US Food and Drug Administration (FDA) 510(k) clearance of the LithoVue Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures. The built-in pressure sensor on the LithoVue Elite ureteroscope tip is designed to allow urologists to make informed, pressure-related clinical decisions.

Cystoscopy and Ureteroscopy Market Report Coverage and Deliverables

The "Cystoscopy and Ureteroscopy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Cystoscopy and Ureteroscopy Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Cystoscopy and Ureteroscopy Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Cystoscopy and Ureteroscopy Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Cystoscopy and Ureteroscopy Market
• Detailed company profiles